Active Brain & Nervous System Cells, Biochemistry & Physiology

Cell Biology and function of the prion protein in health and disease

In plain English

AI plain-English summary

A single misfolded protein, the prion, can convert healthy copies of itself into a destructive chain reaction that destroys the brain in Creutzfeldt-Jakob disease. For decades, researchers lacked a reliable way to grow human prions in the lab, which made it difficult to detect them in patients or test potential treatments. This team has now engineered mouse cancer cells to propagate human prions from multiple strains, including the agent behind mad cow disease. They plan to turn these cells into an automated, highly sensitive bioassay that measures infectious prions in human tissues and bodily fluids. If successful, the assay could become a gold standard for diagnosing prion diseases and validating other diagnostic tests. It would also provide a biomarker to track whether a treatment is working. Because the system can be scaled up to process thousands of samples per year—as the team has already done for mouse prions—it could transform prion disease management from a post-mortem diagnosis into a routine, early-detection tool.

View original technical description
Creutzfeldt-Jakob disease in humans is a severe, rapidly progressive, ultimately fatal, degenerative brain disorder, caused by an infectious agent which is a misfolded version of a normal cellular protein, called the prion protein. The infectious agent replicates by converting the normal prion protein, to a misfolded disease state. Developing cells that can propagate bona-fide human prions has been an important goal of the prion field for decades. We have successfully engineered mouse cancer cells to be able to propagate human prions from a variety of strains including the causative agent of ‘mad cow’ disease. We aim to use these cells to develop highly sensitive and accurate automated cell-based bioassays, which can be used to measure infectious prions in a range of human tissues and bio-fluids from patients. This assay can be a “gold standard” for diagnosis of prions and validation of other diagnostic assays and provide a biomarker for studying response to treatment. It also has the potential to be scaled up to process large numbers of samples per year, as has already been done for the mouse prion bioassay.

View the original record at the funder ↗

Researchers

Azadeh Khalili-Shirazi (Co-Investigator)James Phillips (Co-Investigator)John Collinge (Co-Investigator)Melissa Rayner (Co-Investigator)Simon Mead (Co-Investigator)

Related Research

Grants with similar aims, by meaning.

Cellular pathophysiology of prion-mediated neurodegeneration - a model for understanding protein misfolding disorders
Developing cell lines that propagate human prions
Molecular and phenotypic analysis of prion strains
Cellular mechanisms of prion-mediated neurodegeneration
Cellular mechanisms of Prion Propagation

Original classification

Intramural

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.